Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 25, No 7 (March 1), 2007: pp. 913
© 2007 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2006.09.8988

This Article
Right arrow Full Text (PDF)
Right arrow Erratum (v26,p1018)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Offit, K.
Right arrow Articles by Davis, J. G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Offit, K.
Right arrow Articles by Davis, J. G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

CORRESPONDENCE

In Reply

Kenneth Offit, Kelly Kohut, Donna Bernstein

Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY

Shelly Cummings, Melody White

Cancer Risk Clinic, Department of Medicine, University of Chicago Medical Center, Chicago, IL

Michal Sagi

Department of Human Genetics, Hadassah-Hebrew University Hospital, Jerusalem, Israel

Jessica G. Davis

Division of Human Genetics, Department of Pediatrics, New York-Presbyterian Hospital, New York, NY

As stated in our article, we agree that preimplantation genetic diagnosis for common cancer syndromes "has not been incorporated into common practice,"1 and will not be appropriate in some cases for psychological or other personal reasons. However, increasing physician awareness of assisted reproductive technologies (ART) is not synonymous with imposing discussion of these options on every individual. Without communicating availability of these options to reproductive-age patients, how can they make truly informed decisions? For example, such discussions will come up in the setting of patients of reproductive age with newly diagnosed cancer who may consider ART for fertility preservation, or infertile individuals with cancer predisposing mutations who seek to utilize in vitro fertilization to achieve pregnancy. Oncologists can recognize those instances when ART may be of potential interest to a couple at risk for hereditary cancer, and then make referrals to professionals who can reliably discuss reproductive options with sensitivity to the emotional aspects and ethical issues. In an effort to guide clinicians and policy makers as they attempt to distinguish circumstances for which discussions of preimplantation genetic diagnosis may be appropriate for families affected by cancer, we have recently provided an analytic framework.2 This framework takes into consideration: the age at onset of the disorder, the penetrance of the syndrome, the severity of the syndrome, the means available to decrease genetically acquired cancer risk, the availability of assisted reproduction options and the potential risks of preimplantation genetic diagnosis itself (eg, exposure to exogenous hormones). A broader discussion of the medical aspects, as well as ethical challenges of assisted reproduction will ensure its most responsible transition to clinical practice.

AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST

The authors indicated no potential conflicts of interest.

REFERENCES

1. Offit K, Kohut K, Clagett B, et al: Cancer genetic testing and assisted reproduction. J Clin Oncol 2006 24:4775-4782[Abstract/Free Full Text]

2. Offit, K, Sagi M, Hurley, K: Commentary: Preimplantation genetic diagnosis for cancer syndromes: A new challenge for preventive medicine. JAMA 296:2727-2730, 2006[Free Full Text]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Erratum (v26,p1018)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Offit, K.
Right arrow Articles by Davis, J. G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Offit, K.
Right arrow Articles by Davis, J. G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2007 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online